» Articles » PMID: 20453710

Succinyl-CoA Ligase Deficiency: a Mitochondrial Hepatoencephalomyopathy

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 2010 May 11
PMID 20453710
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

This patient presented on the first day of life with pronounced lactic acidosis with an elevated lactate/pyruvate ratio. Urine organic acids showed Krebs cycle metabolites and mildly elevated methylmalonate and methylcitrate. The acylcarnitine profile showed elevated propionylcarnitine and succinylcarnitine. Amino acids showed elevated glutamic acid, glutamine, proline, and alanine. From the age 2 of mo on, she had elevated transaminases and intermittent episodes of liver failure. Liver biopsy showed steatosis and a decrease of mitochondrial DNA to 50% of control. She had bilateral sensorineural hearing loss. Over the course of the first 2 y of life, she developed a progressively severe myopathy with pronounced muscle weakness eventually leading to respiratory failure, Leigh disease, and recurrent hepatic failure. The hepatic symptoms and the metabolic parameters temporarily improved on treatment with aspartate, but neither muscle symptoms nor brain lesions improved. Laboratory testing revealed a deficiency of succinyl-CoA ligase enzyme activity and protein in fibroblasts because of a novel homozygous mutation in the SUCLG1 gene: c.40A>T (p.M14L). Functional analysis suggests that this methionine is more likely to function as the translation initiator methionine, explaining the pathogenic nature of the mutation. Succinyl-CoA ligase deficiency due to an SUCLG1 mutation is a new cause for mitochondrial hepatoencephalomyopathy.

Citing Articles

Lipopolysaccharide affects metabolic processes and energy homeostasis in the corpus luteum.

Mierzejewski K, Stryinski R, Bogacka I, Golubska M, Carrera M, Kurzynska A Front Mol Biosci. 2025; 11():1523098.

PMID: 39845899 PMC: 11753227. DOI: 10.3389/fmolb.2024.1523098.


Mitochondrial diseases: from molecular mechanisms to therapeutic advances.

Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X Signal Transduct Target Ther. 2025; 10(1):9.

PMID: 39788934 PMC: 11724432. DOI: 10.1038/s41392-024-02044-3.


Integrated multi-omic analyses uncover the effects of aging on cell-type regulation in glucose-responsive tissues.

Xu P, Kong Y, Palmer N, Ng M, Zhang B, Das S Aging Cell. 2024; 23(8):e14199.

PMID: 38932492 PMC: 11320340. DOI: 10.1111/acel.14199.


Vitamin B12 Deficiency and the Nervous System: Beyond Metabolic Decompensation-Comparing Biological Models and Gaining New Insights into Molecular and Cellular Mechanisms.

Mathew A, Di Matteo G, La Rosa P, Barbati S, Mannina L, Moreno S Int J Mol Sci. 2024; 25(1).

PMID: 38203763 PMC: 10778862. DOI: 10.3390/ijms25010590.


Genetics of enzymatic dysfunctions in metabolic disorders and cancer.

Mahe M, Rios-Fuller T, Karolin A, Schneider R Front Oncol. 2023; 13:1230934.

PMID: 37601653 PMC: 10433910. DOI: 10.3389/fonc.2023.1230934.


References
1.
Naini A, Shanske S . Detection of mutations in mtDNA. Methods Cell Biol. 2007; 80:437-63. DOI: 10.1016/S0091-679X(06)80022-1. View

2.
Phillips D, Aponte A, French S, Chess D, Balaban R . Succinyl-CoA synthetase is a phosphate target for the activation of mitochondrial metabolism. Biochemistry. 2009; 48(30):7140-9. PMC: 2766921. DOI: 10.1021/bi900725c. View

3.
Morava E, Steuerwald U, Carrozzo R, Kluijtmans L, Joensen F, Santer R . Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children. Mitochondrion. 2009; 9(6):438-42. DOI: 10.1016/j.mito.2009.08.003. View

4.
Kowluru A, Tannous M, Chen H . Localization and characterization of the mitochondrial isoform of the nucleoside diphosphate kinase in the pancreatic beta cell: evidence for its complexation with mitochondrial succinyl-CoA synthetase. Arch Biochem Biophys. 2002; 398(2):160-9. DOI: 10.1006/abbi.2001.2710. View

5.
Ostergaard E, Hansen F, Sorensen N, Duno M, Vissing J, Larsen P . Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain. 2007; 130(Pt 3):853-61. DOI: 10.1093/brain/awl383. View